表紙
市場調査レポート

Thermalin Diabetes, LLC :製品パイプライン分析

Thermalin Diabetes, LLC - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 314193
出版日 ページ情報 英文 26 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
Thermalin Diabetes, LLC :製品パイプライン分析 Thermalin Diabetes, LLC - Product Pipeline Review - 2015
出版日: 2015年04月30日 ページ情報: 英文 26 Pages
概要

Thermalin Diabetes, LLC は主にインスリン類似体を製造するバイオテクノロジー企業です。同社の治療用タンパク質は糖尿病および関連合併症治療に使われています。

当レポートでは、Thermalin Diabetes, LLC における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Thermalin Diabetes, LLCの基本情報

  • Thermalin Diabetes, LLCの概要
  • 主要情報
  • 企業情報

Thermalin Diabetes, LLC :R&Dの概要

  • 主な治療範囲

Thermalin Diabetes, LLC :パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Thermalin Diabetes, LLC :パイプライン製品の概況

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Thermalin Diabetes, LLC :薬剤プロファイル

  • T-0005
  • Ultra Stable Biphasic Insulin Analogs for Diabetes
  • CHLOROLOG
  • Insulin Analogs 1
  • Insulin Analogs 2
  • Tissue-Selective Insulin Analogs for Diabetes
  • Ultra-Rapid-Acting Insulin Analogs for Diabetes

Thermalin Diabetes, LLC :パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Thermalin Diabetes, LLC :休止中のプロジェクト

Thermalin Diabetes, LLC :本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07012CDB

Summary

Global Markets Direct's, 'Thermalin Diabetes, LLC - Product Pipeline Review - 2015', provides an overview of the Thermalin Diabetes, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Thermalin Diabetes, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Thermalin Diabetes, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Thermalin Diabetes, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Thermalin Diabetes, LLC's pipeline products

Reasons to buy

  • Evaluate Thermalin Diabetes, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Thermalin Diabetes, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Thermalin Diabetes, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Thermalin Diabetes, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Thermalin Diabetes, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Thermalin Diabetes, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Thermalin Diabetes, LLC Snapshot
    • Thermalin Diabetes, LLC Overview
    • Key Information
    • Key Facts
  • Thermalin Diabetes, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • Thermalin Diabetes, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Thermalin Diabetes, LLC - Pipeline Products Glance
    • Thermalin Diabetes, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Thermalin Diabetes, LLC - Drug Profiles
    • T-0005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CHLOROLOG
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Insulin Analogs 1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Insulin Analogs 2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Peptides to Agonize Insulin Receptor for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Tissue-Selective Insulin Analogs for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Ultra-Rapid-Acting Insulin Analogs for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Thermalin Diabetes, LLC - Pipeline Analysis
  • Thermalin Diabetes, LLC - Pipeline Products by Target
  • Thermalin Diabetes, LLC - Pipeline Products by Route of Administration
  • Thermalin Diabetes, LLC - Pipeline Products by Molecule Type
  • Thermalin Diabetes, LLC - Pipeline Products by Mechanism of Action
  • Thermalin Diabetes, LLC - Dormant Projects
  • Thermalin Diabetes, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Thermalin Diabetes, LLC, Key Information
  • Thermalin Diabetes, LLC, Key Facts
  • Thermalin Diabetes, LLC - Pipeline by Indication, 2015
  • Thermalin Diabetes, LLC - Pipeline by Stage of Development, 2015
  • Thermalin Diabetes, LLC - Monotherapy Products in Pipeline, 2015
  • Thermalin Diabetes, LLC - Preclinical, 2015
  • Thermalin Diabetes, LLC - Discovery, 2015
  • Thermalin Diabetes, LLC - Pipeline by Target, 2015
  • Thermalin Diabetes, LLC - Pipeline by Route of Administration, 2015
  • Thermalin Diabetes, LLC - Pipeline by Molecule Type, 2015
  • Thermalin Diabetes, LLC - Pipeline Products by Mechanism of Action, 2015
  • Thermalin Diabetes, LLC - Dormant Developmental Projects,2015

List of Figures

  • Thermalin Diabetes, LLC - Pipeline by Top 10 Indication, 2015
  • Thermalin Diabetes, LLC - Pipeline by Stage of Development, 2015
  • Thermalin Diabetes, LLC - Monotherapy Products in Pipeline, 2015
  • Thermalin Diabetes, LLC - Pipeline by Top 10 Target, 2015
  • Thermalin Diabetes, LLC - Pipeline by Top 10 Molecule Type, 2015
  • Thermalin Diabetes, LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top